Allergan Faces Lawsuit Alleging Payment of Kickbacks to Induce Prescriptions for Lucrative Eye Care Drugs
The lawsuit alleges that
doctors and optometrists prescribe
The complaint was filed under the qui tam, or whistleblower provisions of the False Claims Act.
This Act encourages private citizens to come forward and report fraud against the government by allowing them to sue on behalf of the government and receive a share of any government recovery. Under the law, 70 percent of any recovery goes back to federal and state treasuries.
"Patients deserve to know that their medical professional is making decisions based on their best interests and not because a drug company is offering incentives to steer patients to specific drugs," said Pietragallo Gordon attorney
"It is rare for successful, well-respected physicians to blow the whistle on the health care industry," says Raspanti's partner,
"We are proud to represent our clients who not only run one of the most prestigious eye care practices in the
"The False Claims Act provides private law firms with the unique opportunity to litigate and vindicate the interests of federal and state governments, and we intend to do just that," commented Chizewer's partner,
The lawsuit is captioned
Serving clients and whistleblowers nationwide, the attorneys of
Read the full story at http://www.prweb.com/releases/2013/12/prweb11437565.htm
|Copyright:||(c) 2013 PRWEB.COM Newswire|